Provider of an AI agents platform for the patient journey.
Provider of an AI agents platform for the patient journey. Headquartered in San Francisco, CA. Raised $120M in Series C funding in June 2026 led by Menlo Ventures, at a $1.2B valuation.
Healthcare📍 San Francisco, CAFounded 2020
Current Valuation
$1.2B
as of 2026-Q2
UNICORN
QL Price
$1.2B
0% vs last round
QuantLogix's current estimate for Assort Health, published 2026-09-13 — in line with the last disclosed round of $1.2B (2026-Q2).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$1.2B
2026-Q2
weight 0.87
How this price has held up
No round has priced for Assort Health since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-13 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Assort Health, 2026-09-13 (088dd16fa9de1f6b).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Assort Health going public?
No. Assort Health is private and has not filed to go public. There is no S-1 on file.
What is Assort Health's valuation in 2026?
Assort Health is valued at $1.2B as of 2026-Q2, set by its Series C ($120M, Jun 2026). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Assort Health filed an S-1?
No public S-1 is on file for Assort Health.
Who are Assort Health's investors?
Assort Health's investors include Menlo Ventures, Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Joe Montana and 2 more.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
CEO
Jon Wang and Jeffery Liu
Founded
2020
HQ
San Francisco, CA
Total Raised
$120M
Last Round
Series C — $120M (Jun 2026) · Lead: Menlo Ventures
IPO Status
private
Fundraising Status
Series C · $120M · 3 mo ago
privateTotal raised $120M1 disclosed rounds
Series C Impact
Round Size
$120M
Primary financing announced
Post-Money Valuation
$1.2B
Company-announced mark
Round / Post-Money
10.0%
New capital ÷ post-money
Disclosed Funding
$120M
Cumulative disclosed rounds
Step-up compares disclosed post-money valuations. Round / post-money is a financing-size ratio, not an ownership or dilution estimate.
Funding History
Round
Amount
Date
Lead Investor
Post-Money
Series C
$120M
Jun 2026
Menlo Ventures
$1.2B
Talent Signal
Hiring trend
● First snapshot
trend accrues with monthly sweeps
Open roles
32
via ashby
Product-build share
28%
engineering, research, product, design
Trajectory
steady
balanced build + GTM — 28% builders vs 72% go-to-market/G&A — scaling both sides.
Counted from Assort Health's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Founders & Key People
Jon WangJeffery Liu
Investors
Menlo Ventures · Lightspeed Venture Partners · Felicis · First Round Capital · Chemistry · Joe Montana · Tau Ventures · Quiet Capital
HealthcareDigital HealthUnicornRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2026-Q2. Refreshed quarterly.